Literature DB >> 3226540

Lumbar myelography with iopamidol: a methodological approach to the investigation of side effects.

L Provinciali1, M Signorino, A R Giovagnoli, M Baroni, F Angeleri, U Salvolini, U Pasquini, M Porta, A Judice, R Cerutti.   

Abstract

Pathophysiology of adverse reactions occurring during myelography with non-ionic contrast agents, such as iopamidol, seem related to their direct action on the nervous system. The authors try a multivariate approach, involving neurophysiological, neuropsychological and neurochemical parameters on a pilot group of twelve subjects. Any possible change in the above examinations is thoroughly analyzed and correlated to the postulated neurotoxic properties of contrast media.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3226540     DOI： 10.1007/bf00339695

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


  23 in total

1.  Evaluation of the blood-CSF barrier by protein gradients and the humoral immune response within the central nervous system.

Authors:  K Felgenhauer; G Schliep; N Rapic
Journal:  J Neurol Sci       Date:  1976-11       Impact factor: 3.181

2.  Delayed onset of dexamethasone-dependent cerebral dysfunction following metrizamide myelography.

Authors:  B M Weissman
Journal:  Arch Neurol       Date:  1984-05

3.  Increased permeability of the blood-brain barrier after carotid Renografin-76.

Authors:  M R Sage; B P Drayer; P J Dubois; E R Heinz; D R Osborne
Journal:  AJNR Am J Neuroradiol       Date:  1981 May-Jun       Impact factor: 3.825

4.  Serum-CSF protein gradients, the blood-GSF barrier and the local immune response.

Authors:  G Schliep; K Felgenhauer
Journal:  J Neurol       Date:  1978-05-18       Impact factor: 4.849

5.  EEG disturbances following myelography, cisternography and ventriculography with metrizamide.

Authors:  A Lundervold; O Sortland
Journal:  Acta Radiol Suppl       Date:  1977

6.  Iohexol in lumbar myelography: preliminary results from an open, noncomparative multicenter clinical study.

Authors:  O P Eldevik; P Nakstad; B E Kendall; T Hindmarsh
Journal:  AJNR Am J Neuroradiol       Date:  1983 May-Jun       Impact factor: 3.825

7.  A procedure for recording electroretinogram and visual evoked potential in conscious dogs.

Authors:  S Sato; S Sugimoto; S Chiba
Journal:  J Pharmacol Methods       Date:  1982-11

8.  Cortical blindness after metrizamide myelography. Report of a case and proposed pathophysiologic mechanism.

Authors:  J G Smirniotopoulos; F M Murphy; D Schellinger; J F Kurtzke; F T Borts
Journal:  Arch Neurol       Date:  1984-02

9.  Iopamidol vs metrizamide: a double blind study for cervical myelography.

Authors:  B P Drayer; M A Warner; A Sudilovsky; J Luther; R Wilkins; S Allen; M Bates
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

10.  The effect of position of patient on the passage of metrizamide (Amipaque), meglumine locarmate (Dimer X) and ioserinate (Myelografin) into the blood after lumbar myelography.

Authors:  U Speck; R Schmidt; V Volkhardt; H Vogelsang
Journal:  Neuroradiology       Date:  1978-02-17       Impact factor: 2.804
View more
  2 in total

1.  Effects of ionic and non-ionic paramagnetic contrast media on brain bio-electric activity.

Authors:  A Messori; G Polonara; L Regnicolo; L Provinciali; M Signorino; U Salvolini
Journal:  Neuroradiology       Date:  2005-08-25       Impact factor: 2.804

2.  Electrophysiological and cognitive effects of lumbar myelography with iopamidol: comparison with diagnostic lumbar puncture.

Authors:  L Provinciali; M G Ceravolo; M Signorino; M Baroni; U Pasquini; R Cerrutti; U Salvolini
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.